Rediff Business · Scour

Indian Pharma Market Sees Strong Q4 Growth; Shift to Chronic Therapies

Sensex tumbles 931 points, Nifty plunges to 23,775 amid fading confidence on ceasefire

TCS Q4 Net Profit Jumps 12.22% to Rs 13,718 Crore

RBI may rationalise board norms, shift focus to strategy, policy

KV Kamath Emphasises AI Application and Education Reform for India's Future

Rupee likely to stabilise at 92-93 per dollar: EAC-PM chairman

RBI Governor Sanjay Malhotra on Inflation, Interest Rates, Rupee Volatility, and Banking Health

Tata Power Teams Up with Databricks to Develop AI-Driven Energy Solutions

Govt Cuts Airport Charges By 25%

BMW Beats Mercedes, But Is This a Turning Point?

Stock Markets Today: Sensex, Nifty50 Tumble on Fresh Tensions in West Asia

Rupee surges 52 paise to close at 92.54/USD on US-Iran ceasefire

Cibil CEO: Lenders must engage with customers on credit usage, as they did during pandemic

India's Residential Market Cools, Office Leasing Hits Quarterly High

Haryana's AI Programme Gains Momentum with World Bank Collaboration

Deloitte India and IIT Bombay Collaborate to Advance Quantum Technology

Sensex and Nifty Rally as US-Iran Ceasefire Boosts Global Markets

Biocon eyes global insulin leadership as rivals pivot to GLP-1 therapies

LPG crisis may cut sugar demand by 400,000 tonnes: Isma chief

Oil Price Tumbles as US-Iran Ceasefire Eases Geopolitical Tensions

Log in to enable infinite scrolling